Rejoinder by Sridhar et al.
Dear Editor
1. It is fully accepted that the standard treatment of shock in DHF is indeed intravenous fluids with close monitoring of the vital parameters and aggressive supportive therapy, at times, with colloids when the situation deteriorates and goes out of hand. However, the main thrust of this paper was to caution the reader in a peripheral medical center of the need to consider shifting the child to a better equipped hospital before the condition worsens. In this regard, while it may not be possible to transfer all patients with DHF to a higher center, it may be probably necessary and indeed wise to shift DHF children with clinical features of shock and platelet counts of less than 30,000/mm 3 since these patients (as shown in the paper) do exhibit abnormalities of the coagulation parameters and increased levels of D dimer and are hence at a statistically significant increased risk of bleeding subsequently. This has been repeatedly mentioned in the paper. 2. Sero-positivity has been used as an inclusion criteria in this paper, as the aim was to evaluate the D-dimer levels in children with DHF and correlate these values with the platelet count 3. The efficacy and utility of component transfusion therapy in severe DHF and DSS has been well documented in various studies especially from the Far East. However, it was never our intention to comment categorically on this aspect, as this will require a study of far greater magnitude to do so.
